Strengths
- Public unicorn lists include LetsGetChecked with valuation evidence.
- Company-owned materials describe the product/platform and operating model.
- Public materials include customer, usage or operating-scale signals.
LetsGetChecked Startup Diligence Report
Proceed only to confirmatory diligence. The public record supports continued research into LetsGetChecked, but no investment or transaction conclusion should rely on the headline valuation without private proof of revenue durability, margins, customer retention, legal/regulatory controls and financing terms.
LetsGetChecked Startup Diligence Report
LetsGetChecked is a credible active private-unicorn diligence target based on public unicorn-list evidence and active company materials. Public evidence supports product/category presence and selected traction or operating-scale signals, but financial quality, customer concentration, retention, margin, cap-table economics and legal/control evidence remain private diligence items.
Public sources disclose LetsGetChecked's headline unicorn valuation, but audited financials, ARR, margins, burn, cash and debt are not public.
Diligence request: Request audited financials, KPI pack, cash/debt schedule, board plan and valuation bridge.
Public customer or scale signals do not disclose customer-level ARR, churn, NRR, backlog or contract economics.
Diligence request: Request top-customer schedule, cohort retention, churn/NRR and independent references.
Diagnostics, lab operations, telehealth, pharmacy/prescription fulfillment, patient data and acquisitions create healthcare regulatory, privacy, clinical-quality and integration risks.
Diligence request: Have counsel review litigation, regulatory correspondence, IP assignments, licenses, data/privacy controls and insurance.
LetsGetChecked faces well-funded incumbents and venture-backed peers; public data does not prove durable win rates or pricing power.
Diligence request: Benchmark pricing, win/loss, pipeline conversion and customer references against direct competitors.
Public product claims do not include uptime, quality, safety, roadmap delivery or defect metrics.
Diligence request: Review roadmap, architecture, quality metrics, incident history and engineering capacity.
Public GTM signals do not disclose CAC, payback, quota attainment, channel margin or pipeline quality.
Diligence request: Request sales funnel, channel economics, marketing budget, quota model and pipeline aging.
Public leadership signals are incomplete and do not reveal attrition, compensation, succession or hiring-plan feasibility.
Diligence request: Request org chart, HRIS extract, attrition, compensation plan and retention-risk review.
Public unicorn-list data does not disclose liquidation preferences, option pool, debt, secondary activity or investor-control terms.
Diligence request: Request fully diluted cap table, investor-rights documents, debt instruments and material-contract summaries.
LetsGetChecked's public materials verify unicorn status and headline valuation anchors, but audited financial statements, ARR, margin, cash, debt, retention and cap-table economics were not public.
not publicly verifiable confidence: low
Public diligence for LetsGetChecked found limited public evidence and meaningful private-data gaps for annual and quarterly financial information for the past three years.
| item | public signal | diligence request | priority |
|---|---|---|---|
| Audited financials and management accounts | No audited financial statements or KPI pack found in public sources. | Three-year audited financials, monthly management accounts and budget-to-actuals. | high |
| Revenue quality and retention | Public sources do not disclose ARR, gross margin, churn, NRR or backlog. | ARR bridge, cohort retention, gross margin and bookings/backlog schedule. | high |
| Cap table and debt | Investor/valuation signals are public; ownership, preferences and debt are not. | Fully diluted cap table, investor rights, option pool, warrants and debt instruments. | high |
not publicly verifiable confidence: low
Public diligence for LetsGetChecked found limited public evidence and meaningful private-data gaps for financial projections.
| date | event | amount or valuation | source | verification status |
|---|---|---|---|---|
| 2021-06 | Latest public unicorn valuation anchor | USD 1B+ | Wikipedia candidate list / CB Insights cross-check | verified |
| Public database date | CB Insights unicorn-list entry | USD 1B | CB Insights | verified |
| Current | Detailed financing terms | not publicly verifiable | Private data-room request | not_publicly_verifiable |
Detailed cap table, preferences, debt and secondary activity require private records.
not publicly verifiable confidence: low
Public diligence for LetsGetChecked found limited public evidence and meaningful private-data gaps for capital structure.
not publicly verifiable confidence: low
Public diligence for LetsGetChecked found limited public evidence and meaningful private-data gaps for other financial information.
Public sources describe LetsGetChecked's product portfolio and positioning, but product-level growth, unit economics, roadmap acceptance criteria and profitability by SKU require private data-room support.
partially verified confidence: medium
Public diligence for LetsGetChecked found partial public evidence plus private-data gaps for description of each product.
| product or capability | audience | public evidence | verification status |
|---|---|---|---|
| At-home health testing | Consumers and enterprise populations | Homepage and About Us describe at-home testing and lab analysis. | verified |
| Virtual consultations and treatment | Patients needing follow-up care | About Us and careers describe virtual consultations, prescription fulfillment and telehealth. | verified |
| Enterprise wellness solutions | Employers/healthcare partners | Homepage title includes Enterprise Wellness Solutions; About Us says 5000+ organizations. | partially_verified |
| offer | public pricing signal | private gap | source |
|---|---|---|---|
| Consumer health tests | Product categories are public; exact current prices vary by kit/page. | Margin, refund rates, kit mix and repeat purchase. | Homepage/product pages |
| Enterprise/population programs | Enterprise wellness positioning is public. | Per-member pricing, contract duration and churn. | Homepage/About Us |
| Virtual care/prescription fulfillment | Care lifecycle is public. | Clinical staffing cost, pharmacy economics and regulatory cost. | About Us/careers |
Public evidence shows customer or partner reach for LetsGetChecked; revenue concentration, churn, contract terms and reference quality remain private diligence items.
partially verified confidence: medium
Public diligence for LetsGetChecked found partial public evidence plus private-data gaps for top customers by application.
| signal | evidence | risk or gap | verification status |
|---|---|---|---|
| 5000+ organizations | About Us says delivering at-home healthcare to 5000+ organizations. | Organization mix, contract value and retention not public. | partially_verified |
| 15 million patients/tests-related scale | About Us references tests completed and 15 million patients globally. | Revenue and active-customer recency not public. | partially_verified |
| 7 million clinical interactions | About Us lists clinical interactions metric. | Clinical quality, outcomes and liability data not public. | partially_verified |
partially verified confidence: medium
Public diligence for LetsGetChecked found partial public evidence plus private-data gaps for strategic relationships.
| relationship or dependency | role | public evidence | concentration risk |
|---|---|---|---|
| Fuze Health family | Corporate/platform family | About Us says LetsGetChecked is part of the Fuze Health family. | Corporate structure, control and related-party arrangements need review. |
| BioIQ and Veritas Genetics acquisitions | Portfolio/integration history | About Us states LetsGetChecked acquired BioIQ and Veritas Genetics. | Integration, legacy liabilities and data rights need diligence. |
| Labs/manufacturing/logistics | Critical operating dependencies | Careers and About Us describe in-house infrastructure. | Capacity, quality systems and supply-chain resilience need verification. |
partially verified confidence: medium
Public diligence for LetsGetChecked found partial public evidence plus private-data gaps for revenue by customer.
partially verified confidence: medium
Public diligence for LetsGetChecked found partial public evidence plus private-data gaps for significant relationships severed within the last two years.
partially verified confidence: medium
Public diligence for LetsGetChecked found partial public evidence plus private-data gaps for top suppliers.
LetsGetChecked operates in a competitive market where public evidence supports category participation but not win rates, share, pricing power or defensibility versus scaled rivals.
partially verified confidence: medium
Public diligence for LetsGetChecked found partial public evidence plus private-data gaps for competitive landscape by market segment.
| company | segment | product overlap | differentiator or risk | source |
|---|---|---|---|---|
| LetsGetChecked | At-home diagnostics, virtual care and population health services | Target company | Publicly claims differentiated platform breadth; private win-rate not verified. | Company materials |
| Everlywell | At-home testing | Publicly comparable category | Competitive pressure to validate with customer references. | Analyst market mapping from public category evidence |
| Quest Diagnostics / Labcorp | Diagnostics incumbents | Publicly comparable category | Competitive pressure to validate with customer references. | Analyst market mapping from public category evidence |
| Ro / Hims & Hers | Virtual care and pharmacy | Publicly comparable category | Competitive pressure to validate with customer references. | Analyst market mapping from public category evidence |
| Color Health | Population health programs | Publicly comparable category | Competitive pressure to validate with customer references. | Analyst market mapping from public category evidence |
| axis | target position | competitor pressure | evidence gap |
|---|---|---|---|
| Product breadth | Broad public positioning within its category. | Incumbents and specialists may exceed depth in focused areas. | Win/loss and module attach rates. |
| Distribution reach | Public GTM/channel signals exist. | Scaled rivals may have stronger enterprise procurement or channel density. | CAC, payback, quota attainment and channel profitability. |
| Trust/compliance | Public trust/compliance claims are partial. | Regulated buyers may favor established vendors. | Security, legal, regulatory and reference checks. |
Public materials show direct, partner and digital GTM signals, while pipeline, CAC, quota productivity, payback and budget sufficiency are not publicly verifiable.
partially verified confidence: medium
Public diligence for LetsGetChecked found partial public evidence plus private-data gaps for strategy and implementation.
| channel | public evidence | private metric needed | risk |
|---|---|---|---|
| Direct-to-consumer | Homepage invites personal health journey and lists consumer test categories. | Conversion, repeat purchase and CAC. | Consumer demand can be campaign-dependent. |
| Enterprise/organizations | About Us says 5000+ organizations. | Contract value, renewal, churn and concentration. | Large contracts may be episodic or program-specific. |
| Care delivery infrastructure | Vertical integration across manufacturing, logistics, labs and care. | Capacity utilization and unit economics. | Operational complexity and regulatory overhead. |
partially verified confidence: medium
Public diligence for LetsGetChecked found partial public evidence plus private-data gaps for major customers.
partially verified confidence: medium
Public diligence for LetsGetChecked found partial public evidence plus private-data gaps for principal avenues for generating new business.
| signal | evidence | diligence use | verification status |
|---|---|---|---|
| Patient-first positioning | Homepage emphasizes removing barriers to care. | Evaluate consumer conversion and brand trust. | verified |
| Enterprise wellness positioning | Homepage title includes Enterprise Wellness Solutions. | Assess B2B pipeline and customer concentration. | verified |
| Scale metrics on About Us | 5000+ organizations and 15M patients/test scale signals. | Benchmark traction versus revenue and retention. | partially_verified |
partially verified confidence: medium
Public diligence for LetsGetChecked found partial public evidence plus private-data gaps for sales force productivity model.
partially verified confidence: medium
Public diligence for LetsGetChecked found partial public evidence plus private-data gaps for ability to implement marketing plan with current and projected budgets.
Public sources support the existence of technology, product and R&D activity, but roadmap cost, delivery risk, model/data rights and quality metrics remain private.
partially verified confidence: medium
Public diligence for LetsGetChecked found partial public evidence plus private-data gaps for description of r&d organization.
| area | public evidence | risk or gap | source |
|---|---|---|---|
| Clinical/analytics software | About Us says proprietary clinical and analytics software. | Need software architecture, validation and data-rights review. | About Us |
| Lab/manufacturing operations | Careers says in-house manufacturing and laboratories. | Need quality-system and capacity review. | Careers |
| Telehealth/prescription workflows | About Us and careers describe virtual consultations and pharmacists. | Need clinical protocols and licensure compliance. | About Us/careers |
partially verified confidence: medium
Public diligence for LetsGetChecked found partial public evidence plus private-data gaps for new product pipeline.
| project or release | status | expected private validation | source |
|---|---|---|---|
| 360-degree care provider transition | Company history says acquisitions enabled transition. | Integration roadmap, synergy evidence and product adoption. | About Us |
| Published research / FDA-cleared ImPress device | About Us references published research and FDA cleared ImPress device. | Regulatory file, sales/adoption and IP ownership. | About Us |
| Enterprise healthcare platform | Public enterprise wellness positioning. | B2B roadmap, partner integrations and margin profile. | Homepage |
Public leadership and operating signals identify key personnel or functions, but org charts, compensation, attrition, hiring plan and retention risks require company records.
partially verified confidence: medium
Public diligence for LetsGetChecked found partial public evidence plus private-data gaps for organization chart.
partially verified confidence: medium
Public diligence for LetsGetChecked found partial public evidence plus private-data gaps for historical and projected headcount by function and location.
| function or scale | public signal | private metric needed | source |
|---|---|---|---|
| Healthcare professionals | Careers references doctors, nurses and pharmacists. | Licensed staff count, locations and credentialing. | Careers |
| Engineering/product | Careers references engineering and product teams. | Headcount by function and attrition. | Careers |
| 5000+ organizations / 15M patients | About Us scale metrics. | Current active accounts, revenue and support ratios. | About Us |
partially verified confidence: medium
Public diligence for LetsGetChecked found partial public evidence plus private-data gaps for senior management biographies.
| name | role | public evidence | diligence caveat |
|---|---|---|---|
| Oonagh OBrien | CEO at Fuze Services | Listed on About Us. | Confirm role scope, tenure and reporting lines. |
| Ronan Ryan | Chief Operations Officer | Listed on About Us. | Confirm operating responsibilities and retention. |
| Mike Tesar / Dr. Robert Mordkin / Michael Rummel | CTO / CMO / Chief Laboratory Officer | Listed on About Us. | Confirm team depth and clinical/lab governance. |
partially verified confidence: medium
Public diligence for LetsGetChecked found partial public evidence plus private-data gaps for compensation arrangements.
partially verified confidence: medium
Public diligence for LetsGetChecked found partial public evidence plus private-data gaps for incentive stock plans.
partially verified confidence: medium
Public diligence for LetsGetChecked found partial public evidence plus private-data gaps for significant employee relations problems, past or present.
partially verified confidence: medium
Public diligence for LetsGetChecked found partial public evidence plus private-data gaps for personnel turnover.
Public searches and company materials did not provide a full legal, IP, privacy, insurance or material-contract diligence package; counsel review remains essential.
not publicly verifiable confidence: low
Public diligence for LetsGetChecked found limited public evidence and meaningful private-data gaps for pending lawsuits against the company.
| matter | public evidence | status | request |
|---|---|---|---|
| Healthcare regulatory compliance | Lab testing, consultations, prescription fulfillment and healthcare professionals are public. | partially_verified | Review CLIA/CAP/FDA/state licensure, clinical protocols and pharmacy rules. |
| Privacy/security | Patient data is inherent to testing and care workflows; internal controls not public. | not_publicly_verifiable | Review HIPAA/GDPR controls, SOC reports, incident log and DPAs. |
| Acquisition integration | BioIQ and Veritas Genetics acquisitions disclosed. | partially_verified | Review purchase agreements, legacy liabilities, data rights and integration costs. |
not publicly verifiable confidence: low
Public diligence for LetsGetChecked found limited public evidence and meaningful private-data gaps for pending lawsuits initiated by company.
not publicly verifiable confidence: low
Public diligence for LetsGetChecked found limited public evidence and meaningful private-data gaps for environmental and employee safety issues and liabilities.
not publicly verifiable confidence: low
Public diligence for LetsGetChecked found limited public evidence and meaningful private-data gaps for material patents, copyrights, licenses, and trademarks.
| asset or contract | public signal | gap | priority |
|---|---|---|---|
| Proprietary clinical/analytics software | About Us describes proprietary clinical and analytics software. | Code/IP assignments, data rights and license obligations. | high |
| Clinical protocols and lab licenses | Clinical/lab operations public; license file not public. | Regulatory approvals, quality-system documentation and adverse-event history. | high |
| Enterprise/partner contracts | 5000+ organizations public. | Material customer contracts, BAAs, DPAs, termination rights and SLAs. | high |
not publicly verifiable confidence: low
Public diligence for LetsGetChecked found limited public evidence and meaningful private-data gaps for insurance coverage and material exposures.
not publicly verifiable confidence: low
Public diligence for LetsGetChecked found limited public evidence and meaningful private-data gaps for material contracts.
not publicly verifiable confidence: low
Public diligence for LetsGetChecked found limited public evidence and meaningful private-data gaps for regulatory agency problems.
| ID | Claim | Status | Sources |
|---|---|---|---|
| EC-001 | LetsGetChecked appears on public unicorn lists with latest valuation evidence. | verified high | SRC-001SRC-002 |
| EC-002 | LetsGetChecked publicly offers at-home health testing, virtual consultations, prescription fulfillment and enterprise wellness/health solutions. | verified medium | SRC-003SRC-004SRC-005 |
| EC-003 | LetsGetChecked has public monetization or product packaging signals. | partially verified medium | SRC-003SRC-007 |
| EC-004 | LetsGetChecked publicly states it delivers at-home healthcare to 5000+ organizations and has served large patient/test volumes. | partially verified medium | SRC-004 |
| EC-005 | LetsGetChecked's detailed financial statements, cap table and debt instruments were not found in public research. | not publicly verifiable low | SRC-001SRC-002 |
| EC-006 | LetsGetChecked operates in At-home diagnostics, virtual care and population health services with identifiable competitors. | partially verified medium | SRC-003SRC-004SRC-005 |
| EC-007 | LetsGetChecked uses direct-to-consumer, enterprise/partner and vertically integrated care delivery channels. | partially verified medium | SRC-003SRC-004SRC-005 |
| EC-008 | LetsGetChecked has public R&D/technology signals around proprietary clinical/analytics software, lab operations and healthcare research. | partially verified medium | SRC-004SRC-005 |
| EC-009 | LetsGetChecked publicly lists CEO, COO, CTO, CMO and Chief Laboratory Officer roles on About Us. | partially verified medium | SRC-004 |
| EC-010 | LetsGetChecked's full IP, litigation, insurance and material-contract package is not public. | not publicly verifiable low | SRC-003SRC-004SRC-005 |
| EC-011 | LetsGetChecked operates in regulated diagnostics, lab, telehealth, privacy and prescription-fulfillment domains. | partially verified medium | SRC-003SRC-004SRC-005 |
| EC-012 | LetsGetChecked appears eligible for this run as an uncovered active private unicorn. | partially verified medium | SRC-001SRC-002SRC-003SRC-004 |
| EC-013 | LetsGetChecked publicly reports 5000+ organizations, 15 million patients/tests-related scale signals and 7 million clinical interactions, but revenue mix is private. | partially verified medium | SRC-004 |
| ID | Publisher | Title | Accessed |
|---|---|---|---|
| SRC-001 | CB Insights | CB Insights - The Complete List Of Unicorn Companies | 2026-06-04 |
| SRC-002 | Wikipedia | Wikipedia - List of unicorn startup companies | 2026-06-04 |
| SRC-003 | LetsGetChecked | LetsGetChecked homepage | 2026-06-04 |
| SRC-004 | LetsGetChecked | LetsGetChecked About Us | 2026-06-04 |
| SRC-005 | LetsGetChecked | LetsGetChecked careers | 2026-06-04 |
| SRC-006 | Fuze Health | Fuze Health | 2026-06-04 |
| SRC-007 | LetsGetChecked | LetsGetChecked product pages | 2026-06-04 |
This report is a public-evidence diligence snapshot, not investment advice. Important financial, legal, technical, and contractual facts remain non-public and should be verified directly with management and primary documents before any investment decision.